sábado, 13 de diciembre de 2014

MMWR News Synopsis for December 11, 2014

MMWR News Synopsis for December 11, 2014

MMWR- Morbidity and Mortality Weekly Report

MMWR News Synopsis for December 11, 2014 

State Laws and Electronic Nicotine Delivery Systems — United States, September 2014

Electronic Nicotine Delivery Systems (ENDS), including e-cigarettes, should not be used by youth and adult non-tobacco users because of the adverse effects of nicotine and other risk exposures, as well as the risk for progression to other forms of tobacco use. As of November 30, 2014, 40 states have enacted laws prohibiting ENDS sales to minors, but only three of the 26 states and the District of Columbia that have comprehensive smoke-free air laws have incorporated ENDS. 

Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination — United States, 2013–14 Influenza Season

Influenza vaccination can prevent a substantial number of flu cases and hospitalizations each year and should continue to be offered to all persons 6 months of age and older throughout the flu season. CDC recommends yearly influenza vaccination for all people 6 months of age and older in the United States as the best way to prevent flu and its complications.

Incidence of Sickle Cell Trait — United States, 2010

People who have sickle cell trait should be properly informed of their status and educated about possible health implications and reproductive decisions. We estimate that over 60,000 babies were born with sickle cell trait in 2010. Although the occurrence of sickle cell trait (SCT) varies greatly from state-to-state and among different races and ethnicities, every state and racial/ethnic population includes persons living with the condition.

Global Invasive Bacterial Vaccine-Preventable Diseases Surveillance, 2008–2014

Consistent and high-quality sentinel hospital surveillance provides critical public health data to inform decisions made by countries regarding new vaccine introduction and use. Meningitis and pneumonia are leading causes of morbidity and mortality in children globally. Since 2007, the World Health Organization (WHO) has recommended using pneumococcal conjugate vaccine (PCV) in childhood immunization programs.

No hay comentarios: